Vanda Pharmaceuticals Inc. (VNDA)
NASDAQ: VNDA · Real-Time Price · USD
3.820
+0.230 (6.41%)
At close: Nov 6, 2026, 4:00 PM EST
3.860
+0.040 (1.05%)
Pre-market: Nov 9, 2026, 7:00 AM EST
Vanda Pharmaceuticals Market Cap
Vanda Pharmaceuticals has a market cap or net worth of $230.99 million as of November 6, 2026. It is the 19,565th most valuable company in the world and the 3,424th biggest in the United States. Its market cap has decreased by 11.97% in one year.
Market Cap
230.99M
Enterprise Value
112.47M
1-Year Change
-11.97%
Global Rank
Country Rank
#3,424 United States
Category
ChartMarket Cap Chart
Since April 12, 2006, Vanda Pharmaceuticals's market cap has increased from $209.50M to $230.99M, an increase of 10.26%. That is a compound annual growth rate of 0.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 6, 2026 | 231.00M | -55.68% |
| Dec 31, 2025 | 521.20M | 86.61% |
| Dec 31, 2024 | 279.30M | 15.03% |
| Dec 29, 2023 | 242.80M | -41.94% |
| Dec 30, 2022 | 418.20M | -52.16% |
| Dec 31, 2021 | 874.10M | 21.64% |
| Dec 31, 2020 | 718.60M | -17.90% |
| Dec 31, 2019 | 875.30M | -36.13% |
| Dec 31, 2018 | 1.37B | 100.69% |
| Dec 29, 2017 | 682.90M | -2.57% |
| Dec 30, 2016 | 700.90M | 75.84% |
| Dec 31, 2015 | 398.60M | -17.90% |
| Dec 31, 2014 | 485.50M | 17.87% |
| Dec 31, 2013 | 411.90M | 294.54% |
| Dec 31, 2012 | 104.40M | -21.97% |
| Dec 30, 2011 | 133.80M | -49.57% |
| Dec 31, 2010 | 265.30M | -13.30% |
| Dec 31, 2009 | 306.00M | 2,200.75% |
| Dec 31, 2008 | 13.30M | -92.75% |
| Dec 31, 2007 | 183.40M | -66.04% |
| Dec 29, 2006 | 540.00M | 157.76% |
| Apr 12, 2006 | 209.50M | - |
View and export this data all the way back to 2006. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Evommune | 243.52M |
| Abeona Therapeutics | 241.60M |
| Camp4 Therapeutics | 240.03M |
| Lexeo Therapeutics | 239.56M |
| Immuneering | 229.91M |
| Fate Therapeutics | 228.86M |
| Korro Bio | 228.25M |
| Greenwich LifeSciences | 228.10M |